226 related articles for article (PubMed ID: 20827109)
1. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years.
Fernández-Cruz A; Muñoz P; Mohedano R; Valerio M; Marín M; Alcalá L; Rodriguez-Créixems M; Cercenado E; Bouza E
Medicine (Baltimore); 2010 Sep; 89(5):319-330. PubMed ID: 20827109
[TBL] [Abstract][Full Text] [Related]
2. [Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia].
González-Abad MJ; Alonso-Sanz M
Rev Esp Quimioter; 2013 Jun; 26(2):92-6. PubMed ID: 23817644
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008.
Liao CH; Chuang CY; Huang YT; Lee PI; Hsueh PR
J Infect; 2012 Nov; 65(5):392-9. PubMed ID: 22771419
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
6. Campylobacter bacteraemia: 16 years of experience in a single centre.
Hussein K; Raz-Pasteur A; Shachor-Meyouhas Y; Geffen Y; Oren I; Paul M; Kassis I
Infect Dis (Lond); 2016; 48(11-12):796-9. PubMed ID: 27320494
[TBL] [Abstract][Full Text] [Related]
7. Demographic and clinical characteristics of Campylobacter bacteremia in children with and without predisposing factors.
Ben-Shimol S; Carmi A; Greenberg D
Pediatr Infect Dis J; 2013 Nov; 32(11):e414-8. PubMed ID: 23694835
[TBL] [Abstract][Full Text] [Related]
8. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiological characteristics of patients with bacteremia caused by Campylobacter species with an emphasis on the subspecies of C. fetus.
Liu YH; Yamazaki W; Huang YT; Liao CH; Sheng WH; Hsueh PR
J Microbiol Immunol Infect; 2019 Feb; 52(1):122-131. PubMed ID: 28801089
[TBL] [Abstract][Full Text] [Related]
10. [A study of 30 patients with bacteremia due to Campylobacter spp].
Font C; Cruceta A; Moreno A; Miró O; Coll-Vinent B; Almela M; Mensa J
Med Clin (Barc); 1997 Mar; 108(9):336-40. PubMed ID: 9139156
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.
Pigrau C; Bartolome R; Almirante B; Planes AM; Gavalda J; Pahissa A
Clin Infect Dis; 1997 Dec; 25(6):1414-20. PubMed ID: 9431389
[TBL] [Abstract][Full Text] [Related]
12. Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus-infected patients.
Meier PA; Dooley DP; Jorgensen JH; Sanders CC; Huang WM; Patterson JE
J Infect Dis; 1998 Apr; 177(4):951-4. PubMed ID: 9534967
[TBL] [Abstract][Full Text] [Related]
13. Campylobacter bacteraemia in England and Wales, 1981-91.
Skirrow MB; Jones DM; Sutcliffe E; Benjamin J
Epidemiol Infect; 1993 Jun; 110(3):567-73. PubMed ID: 8519321
[TBL] [Abstract][Full Text] [Related]
14. [Invasive Campylobacter jejuni/coli Infections: 9 Case Reports at a Single Center between 2000 and 2015, and a Review of Literature Describing Japanese Patients].
Tasaka K; Matsubara K; Nigami H; Iwata A; Isome K; Yamamoto G
Kansenshogaku Zasshi; 2016 May; 90(3):297-304. PubMed ID: 27529964
[TBL] [Abstract][Full Text] [Related]
15. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994.
Schønheyder HC; Søgaard P; Frederiksen W
Scand J Infect Dis; 1995; 27(2):145-8. PubMed ID: 7660078
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter bacteremia: clinical features and factors associated with fatal outcome.
Pacanowski J; Lalande V; Lacombe K; Boudraa C; Lesprit P; Legrand P; Trystram D; Kassis N; Arlet G; Mainardi JL; Doucet-Populaire F; Girard PM; Meynard JL;
Clin Infect Dis; 2008 Sep; 47(6):790-6. PubMed ID: 18699745
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review.
Tee W; Mijch A
Clin Infect Dis; 1998 Jan; 26(1):91-6. PubMed ID: 9455515
[TBL] [Abstract][Full Text] [Related]
18. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
19. Campylobacter bacteremia in London: A 44-year single-center study.
O'Hara GA; Fitchett JRA; Klein JL
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):67-71. PubMed ID: 28629878
[TBL] [Abstract][Full Text] [Related]
20. [Effects induced by the introduction of highly active antiretroviral therapy (HAART) on disseminated bacterial infection during HIV disease].
Manfredi R; Chiodo F
Infez Med; 2002 Jun; 10(2):107-14. PubMed ID: 12702888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
